Technological advancements in artificial organ industry and growing geriatric population to drive United States artificial organs market
According to TechSci Research report, “United States Artificial Organs Market By Organ Type (Artificial Heart (Prosthetic Heart Valves, Ventricular Assist Devices, Cardiac Pacemakers), Artificial Kidney, Artificial Pancreas, Artificial Lungs, Cochlear Implants, Others), By Technology (Electronic Bionics, Mechanical), By Type of Fixation (Wearable, Implantable), By Material Type (Silicon, Plastic, Steel), By Region, Forecast & Opportunities, 2025”, the United States artificial organs market is expected to witness substantial growth rate during the forecast period owing to the increasing technological and medical advancements in artificial organ manufacturing industry in the country. The country has world’s most advanced healthcare facilities, which is serving as one of the major factors for the growth of this market. Moreover, growing awareness towards health and rising per capita income of the country is also enabling patients to opt for artificial organ transplants. With increasing funding from government in healthcare sector, the artificial organ market in United States is anticipated to witness significant growth over the coming years. Additionally, lack of sufficient number of organ donors is a major concern for United States, thereby fueling the market. Adding to this, growing geriatric population is also acting as a key driving factor for the market as it is more prone to organ failures compared to youths and other tender aged population. Furthermore, increasing cases of chronic disorders affecting one or multiple vital organs is also creating demand for artificial organ transplant in United States. Moreover, manufacturers are now using bioartificial materials, which has led to wide acceptance of artificial organs in the country.
However, United States artificial organs market is also facing some major challenges. Significant rise in cases of product failure after transplantation and organs susceptibility to infections are some major factors hampering the growth of artificial organs market in the country. Also, high cost of artificial organs is further expected to limit the growth of the market.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "United States Artificial Organs Market"
The United States artificial organs market is segmented based on organ type, technology, type of fixation, material type and region. Based on material type, the United States artificial organs market is categorized into silicon, plastic and steel. Among these, the silicon segment is expected to dominate the market during forecast period owing to its increasing acceptance as it is capable of enduring high temperature. Additionally, the manufacturers are also using silicon as the key material for artificial organs. Based on organ type, the United States artificial organs market is segmented into artificial heart, artificial kidney, artificial pancreas, artificial lungs, cochlear implants and others. Out of these, the artificial heart segment is further categorized into prosthetic heart valves, ventricular assist devices and cardiac pacemakers. Among them, artificial kidney segment is expected to register highest demand and expected to undergo fastest growth in the country until 2025 owing to the growing number of patients suffering from kidney disorders.
Major players operating in the United States artificial organs market include B. Braun Medical, Inc. , Abiomed, Inc., Baxter International, Inc. , Jarvik Heart, Inc., Medtronic, Inc., HeartWare International, Inc., SynCardia Systems, LLC , Boston Scientific Corporation, Terumo Medical Corporation, Edwards Lifesciences Corporation and others. The companies are consistently focusing on new product launches to enhance their product portfolios. They are also adopting other growth strategies such as mergers & partnerships to increase their market share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4824
Customers can also request for 10% free customization on this report.
“United States is a leading market for artificial organs compared to other countries. The country with its more aware population and world-class healthcare facilities is a center for artificial organ transplants. The country is also home to some of the world’s leading artificial organ manufacturers. With Trump administrations’ focus on investing more on healthcare, the market is expected to undergo formidable growth in the years to come, ” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Artificial Organs Market By Organ Type (Artificial Heart (Prosthetic Heart Valves, Ventricular Assist Devices, Cardiac Pacemakers), Artificial Kidney, Artificial Pancreas, Artificial Lungs, Cochlear Implants, Others), By Technology (Electronic Bionics, Mechanical), By Type of Fixation (Wearable, Implantable), By Material Type (Silicon, Plastic, Steel), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of United States artificial organs market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in United States artificial organs market.
Browse Related Reports
Europe Biosimilar Insulin Glargine & Lispro Market By End User (Type 1 Diabetes and Type 2 Diabetes),By Country (Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Poland, The Netherlands, Austria & Rest of Europe), Competition, Forecast & Opportunities, 2024
Asia Pacific Biosimilar Insulin Glargine & Lispro Market By End User (Type 1 Diabetes and Type 2 Diabetes), By Country (Japan, China, India, South Korea, Bangladesh, Pakistan), Competition, Forecast & Opportunities, 2024
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
No comments:
Post a Comment